- Home
- TNGX vs ECVT Comparison
TNGX vs ECVT Comparison
Compare TNGX & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ECVT
- Stock Information
- Founded
- TNGX 2014
- ECVT 1935
- Country
- TNGX United States
- ECVT United States
- Employees
- TNGX N/A
- ECVT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ECVT Major Chemicals
- Sector
- TNGX Health Care
- ECVT Industrials
- Exchange
- TNGX Nasdaq
- ECVT Nasdaq
- Market Cap
- TNGX 1.0B
- ECVT 926.8M
- IPO Year
- TNGX N/A
- ECVT 2017
- Fundamental
- Price
- TNGX $7.99
- ECVT $8.42
- Analyst Decision
- TNGX Strong Buy
- ECVT Buy
- Analyst Count
- TNGX 6
- ECVT 3
- Target Price
- TNGX $10.80
- ECVT $12.17
- AVG Volume (30 Days)
- TNGX 4.3M
- ECVT 953.5K
- Earning Date
- TNGX 11-04-2025
- ECVT 11-04-2025
- Dividend Yield
- TNGX N/A
- ECVT N/A
- EPS Growth
- TNGX N/A
- ECVT N/A
- EPS
- TNGX N/A
- ECVT N/A
- Revenue
- TNGX $66,501,000.00
- ECVT $779,193,000.00
- Revenue This Year
- TNGX $20.41
- ECVT $9.34
- Revenue Next Year
- TNGX N/A
- ECVT $1.83
- P/E Ratio
- TNGX N/A
- ECVT N/A
- Revenue Growth
- TNGX 53.29
- ECVT 12.06
- 52 Week Low
- TNGX $1.03
- ECVT $5.24
- 52 Week High
- TNGX $9.70
- ECVT $9.69
- Technical
- Relative Strength Index (RSI)
- TNGX 49.39
- ECVT 51.72
- Support Level
- TNGX $7.12
- ECVT $7.41
- Resistance Level
- TNGX $8.17
- ECVT $8.50
- Average True Range (ATR)
- TNGX 0.74
- ECVT 0.25
- MACD
- TNGX -0.07
- ECVT 0.04
- Stochastic Oscillator
- TNGX 45.74
- ECVT 83.61
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.